Marinus Pharmaceuticals Stock Price on September 27, 2024
| MRNS Stock | USD 0.32 0.01 3.03% |
Below is the normalized historical share price chart for Marinus Pharmaceuticals extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Marinus Pharmaceuticals stands at 0.32, as last reported on the 29th of November, with the highest price reaching 0.33 and the lowest price hitting 0.31 during the day.
If you're considering investing in Marinus Stock, it is important to understand the factors that can impact its price. Marinus Pharmaceuticals has Sharpe Ratio of -0.0544, which conveys that the firm had a -0.0544% return per unit of risk over the last 3 months. Marinus Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Marinus Pharmaceuticals' Mean Deviation of 5.71, standard deviation of 12.45, and Risk Adjusted Performance of (0.03) to check out the risk estimate we provide.
At this time, Marinus Pharmaceuticals' Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 618.1 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 35.9 K in 2024. . At this time, Marinus Pharmaceuticals' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 36.59 in 2024, whereas Price Earnings Ratio is likely to drop (4.34) in 2024. Marinus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2014 | 200 Day MA 2.8725 | 50 Day MA 1.0353 | Beta 1.262 |
Marinus |
Sharpe Ratio = -0.0544
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MRNS |
Estimated Market Risk
| 12.72 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.69 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Marinus Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Marinus Pharmaceuticals by adding Marinus Pharmaceuticals to a well-diversified portfolio.
Price Book 3.1717 | Enterprise Value Ebitda (34.47) | Price Sales 0.5923 | Shares Float 37.4 M | Wall Street Target Price 1.4667 |
Related Headline
89bio Headline on 27th of September 2024
Disposition of 9671 shares by Mansbach Harry H of 89bio at 1... by Mansbach Harry H
Filed transaction by 89bio Inc Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Marinus Pharmaceuticals Valuation on September 27, 2024
It is possible to determine the worth of Marinus Pharmaceuticals on a given historical date. On September 27, 2024 Marinus was worth 1.75 at the beginning of the trading date compared to the closed value of 1.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Marinus Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Marinus Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Marinus Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Marinus Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.75 | 1.77 | 1.72 | 1.73 | 339,350 | |
09/27/2024 | 1.75 | 1.86 | 1.72 | 1.84 | 572,702 |
| 1.82 | 1.88 | 1.74 | 1.76 | 444,360 |
| Backtest Marinus Pharmaceuticals | | | Marinus Pharmaceuticals History | | | Marinus Pharmaceuticals Valuation | Previous | Next |
Marinus Pharmaceuticals Trading Date Momentum on September 27, 2024
| On September 30 2024 Marinus Pharmaceuticals was traded for 1.76 at the closing time. The top price for the day was 1.88 and the lowest listed price was 1.74 . The trading volume for the day was 444.4 K. The trading history from September 30, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.35% . The trading delta at closing time against the current closing price is 3.26% . |
Marinus Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Marinus Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Marinus Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Marinus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Marinus Pharmaceuticals Stock history
Marinus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Marinus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Marinus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Marinus Pharmaceuticals stock prices may prove useful in developing a viable investing in Marinus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 53.7 M | 56.4 M | |
| Net Loss | -17.8 M | -18.7 M |
Marinus Pharmaceuticals Quarterly Net Working Capital |
|
Marinus Pharmaceuticals Stock Technical Analysis
Marinus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Marinus Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Marinus Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Marinus Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Marinus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Marinus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Marinus Pharmaceuticals stock market strength indicators, traders can identify Marinus Pharmaceuticals entry and exit signals to maximize returns
Marinus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Marinus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Marinus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Marinus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.90) | |||
| Total Risk Alpha | (2.58) | |||
| Treynor Ratio | (0.44) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Marinus Stock Analysis
When running Marinus Pharmaceuticals' price analysis, check to measure Marinus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marinus Pharmaceuticals is operating at the current time. Most of Marinus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Marinus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marinus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Marinus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.